Low doses in mice have can clear up proteins associated with Alzheimer’s disease and restore memory. Human trials are the next step. Lithium has long been a standard treatment in bipolar disorder, but ...
ATLANTA, Nov. 19, 2025 /PRNewswire/ -- Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel ...
Topline data expected in first quarter of 2026 Head-to-head studies of AL001 versus a marketed lithium carbonate product was conducted for comparisons of lithium blood and brain/brain-structure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback